NexgenRx, Inc. (NXG.V)

TSXV - TSXV Delayed Price. Currency in CAD
0.19+0.02 (+11.76%)
At close: 1:56 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.17
Bid0.18 x
Ask0.19 x
Day's Range0.18 - 0.19
52wk Range0.14 - 0.20
1y Target EstN/A
Market Cap11.17M
P/E Ratio (ttm)-63.33
Avg Vol (3m)66,215
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • NexgenRx, Inc. :NXG-CA: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
    Capital Cube10 days ago

    NexgenRx, Inc. :NXG-CA: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016

    Categories: Yahoo Finance Get free summary analysis NexgenRx, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of NexgenRx, Inc. – PharMerica Corporation, Express Scripts Holding Company and Ligand Pharmaceuticals Incorporated (PMC-US, ESRX-US and LGND-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)

  • Marketwired29 days ago

    NexgenRx Announces Q2 2016 Results

    NEXGENRX INC. announces revenue of $1,565,891 an increase of $394,280 over the same period last year. Gross profit was $1,278,834 up $349,162 producing net quarterly income of $89,363. Revenue for the ...

  • Marketwired3 months ago

    NexgenRx Announces New Directors

    NEXGENRX INC. announces the election of two new directors at its recently held annual and special meeting of its shareholders. Connie Graham of London, Ontario and Catherine Novick of Toronto, Ontario, ...